Literature DB >> 27926647

Central Fetal Monitoring With and Without Computer Analysis: A Randomized Controlled Trial.

Inês Nunes1, Diogo Ayres-de-Campos, Austin Ugwumadu, Pina Amin, Philip Banfield, Antony Nicoll, Simon Cunningham, Paulo Sousa, Cristina Costa-Santos, João Bernardes.   

Abstract

OBJECTIVE: To evaluate whether intrapartum fetal monitoring with computer analysis and real-time alerts decreases the rate of newborn metabolic acidosis or obstetric intervention when compared with visual analysis.
METHODS: A randomized clinical trial carried out in five hospitals in the United Kingdom evaluated women with singleton, vertex fetuses of 36 weeks of gestation or greater during labor. Continuous central fetal monitoring by computer analysis and online alerts (experimental arm) was compared with visual analysis (control arm). Fetal blood sampling and electrocardiographic ST waveform analysis were available in both arms. The primary outcome was incidence of newborn metabolic acidosis (pH less than 7.05 and base deficit greater than 12 mmol/L). Prespecified secondary outcomes included operative delivery, use of fetal blood sampling, low 5-minute Apgar score, neonatal intensive care unit admission, hypoxic-ischemic encephalopathy, and perinatal death. A sample size of 3,660 per group (N=7,320) was planned to be able to detect a reduction in the rate of metabolic acidosis from 2.8% to 1.8% (two-tailed α of 0.05 with 80% power).
RESULTS: From August 2011 through July 2014, 32,306 women were assessed for eligibility and 7,730 were randomized: 3,961 to computer analysis and online alerts, and 3,769 to visual analysis. Baseline characteristics were similar in both groups. Metabolic acidosis occurred in 16 participants (0.40%) in the experimental arm and 22 participants (0.58%) in the control arm (relative risk 0.69 [0.36-1.31]). No statistically significant differences were found in the incidence of secondary outcomes.
CONCLUSION: Compared with visual analysis, computer analysis of fetal monitoring signals with real-time alerts did not significantly reduce the rate of metabolic acidosis or obstetric intervention. A lower-than-expected rate of newborn metabolic acidosis was observed in both arms of the trial. CLINICAL TRIAL REGISTRATION: ISRCTN Registry, http://www.isrctn.com, ISRCTN42314164.

Entities:  

Mesh:

Year:  2017        PMID: 27926647     DOI: 10.1097/AOG.0000000000001799

Source DB:  PubMed          Journal:  Obstet Gynecol        ISSN: 0029-7844            Impact factor:   7.661


  5 in total

1.  Computer-based intrapartum fetal monitoring and beyond: A review of the 2nd Workshop on Signal Processing and Monitoring in Labor (October 2017, Oxford, UK).

Authors:  Antoniya Georgieva; Patrice Abry; Václav Chudáček; Petar M Djurić; Martin G Frasch; René Kok; Christopher A Lear; Sebastiaan N Lemmens; Inês Nunes; Aris T Papageorghiou; Gerald J Quirk; Christopher W G Redman; Barry Schifrin; Jiri Spilka; Austin Ugwumadu; Rik Vullings
Journal:  Acta Obstet Gynecol Scand       Date:  2019-06-18       Impact factor: 3.636

2.  Computerised interpretation of fetal heart rate during labour (INFANT): a randomised controlled trial.

Authors: 
Journal:  Lancet       Date:  2017-03-21       Impact factor: 79.321

3.  Complexity of Cardiotocographic Signals as A Predictor of Labor.

Authors:  João Monteiro-Santos; Teresa Henriques; Inês Nunes; Célia Amorim-Costa; João Bernardes; Cristina Costa-Santos
Journal:  Entropy (Basel)       Date:  2020-01-16       Impact factor: 2.524

Review 4.  Applications of artificial intelligence in the thorax: a narrative review focusing on thoracic radiology.

Authors:  Yisak Kim; Ji Yoon Park; Eui Jin Hwang; Sang Min Lee; Chang Min Park
Journal:  J Thorac Dis       Date:  2021-12       Impact factor: 2.895

5.  Heart rate markers for prediction of fetal acidosis in an experimental study on fetal sheep.

Authors:  Louise Ghesquière; C Ternynck; D Sharma; Y Hamoud; R Vanspranghels; L Storme; V Houfflin-Debarge; J De Jonckheere; C Garabedian
Journal:  Sci Rep       Date:  2022-06-23       Impact factor: 4.996

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.